Top-Rated StocksTop-RatedNYSE:PHR Phreesia (PHR) Stock Forecast, Price & News $18.63 +0.78 (+4.37%) (As of 09/28/2023 ET) Add Compare Share Share Today's Range$17.57▼$18.6350-Day Range$17.62▼$31.9152-Week Range$17.44▼$40.00Volume607,645 shsAverage Volume423,188 shsMarket Capitalization$1.03 billionP/E RatioN/ADividend YieldN/APrice Target$37.15 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Phreesia MarketRank™ ForecastAnalyst RatingModerate Buy2.85 Rating ScoreUpside/Downside99.4% Upside$37.15 Price TargetShort InterestHealthy3.13% of Shares Sold ShortDividend StrengthN/ASustainability-0.60Upright™ Environmental ScoreNews SentimentN/AInsider TradingSelling Shares$454,810 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($2.64) to ($2.00) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.78 out of 5 starsMedical Sector71st out of 969 stocksHealth Information Services Industry1st out of 2 stocks 4.4 Analyst's Opinion Consensus RatingPhreesia has received a consensus rating of Moderate Buy. The company's average rating score is 2.85, and is based on 11 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $37.15, Phreesia has a forecasted upside of 99.4% from its current price of $18.63.Amount of Analyst CoveragePhreesia has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 4.0 Short Interest Percentage of Shares Shorted3.13% of the outstanding shares of Phreesia have been sold short.Short Interest Ratio / Days to CoverPhreesia has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Phreesia has recently decreased by 15.20%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldPhreesia does not currently pay a dividend.Dividend GrowthPhreesia does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScorePhreesia has received a 60.31% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Patient flow management systems", "Health care management software", and "Personal health record software" products. See details.Environmental SustainabilityThe Environmental Impact score for Phreesia is -0.60. Previous Next 2.6 News and Social Media Coverage News SentimentPhreesia has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Phreesia this week, compared to 2 articles on an average week.Search Interest2 people have searched for PHR on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows4 people have added Phreesia to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Phreesia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $454,810.00 in company stock.Percentage Held by InsidersOnly 5.80% of the stock of Phreesia is held by insiders.Percentage Held by Institutions94.37% of the stock of Phreesia is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Phreesia are expected to grow in the coming year, from ($2.64) to ($2.00) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Phreesia is -6.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Phreesia is -6.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPhreesia has a P/B Ratio of 4.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Phreesia (NYSE:PHR) StockPhreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Wilmington, Delaware.Read More PHR Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PHR Stock News HeadlinesSeptember 21, 2023 | msn.comPhreesia: Share Price Dip Is A Buying OpportunitySeptember 15, 2023 | finance.yahoo.comInsider Sell: Evan Roberts Sells 3,907 Shares of Phreesia Inc (PHR)September 28, 2023 | Legacy Research (Ad)Watch SHOCKING Footage of AI Facility with Ties to Elon MuskI recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.September 15, 2023 | finance.yahoo.comPrincipal Accounting Officer Janet Gunzburg Sells 934 Shares of Phreesia IncSeptember 13, 2023 | msn.comPiper Sandler Maintains Phreesia (PHR) Overweight RecommendationSeptember 11, 2023 | msn.comRaymond James Maintains Phreesia (PHR) Outperform RecommendationSeptember 8, 2023 | msn.comCanaccord Genuity Maintains Phreesia (PHR) Buy RecommendationSeptember 7, 2023 | msn.comRBC Capital Maintains Phreesia (PHR) Sector Perform RecommendationSeptember 28, 2023 | Chaikin Analytics (Ad)This is the #1 Stock to Buy for the AI Tidal WaveMarc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.September 7, 2023 | markets.businessinsider.comExpert Ratings for PhreesiaSeptember 7, 2023 | markets.businessinsider.comThese Analysts Slash Their Forecasts On Phreesia Following Q2 ResultsSeptember 7, 2023 | finance.yahoo.comCompared to Estimates, Phreesia (PHR) Q2 Earnings: A Look at Key MetricsSeptember 7, 2023 | finance.yahoo.comIs Phreesia (PHR) Too Good to Be True? A Comprehensive Analysis of a Potential Value TrapSeptember 7, 2023 | finance.yahoo.comPhreesia Inc (PHR): A Deep Dive into Its Performance PotentialSeptember 7, 2023 | finance.yahoo.comQ2 2024 Phreesia Inc Earnings CallSeptember 7, 2023 | finance.yahoo.comPhreesia, Inc. (NYSE:PHR) Q2 2024 Earnings Call TranscriptSeptember 6, 2023 | uk.finance.yahoo.comPhreesia Announces Second Quarter Fiscal 2024 ResultsSeptember 6, 2023 | seekingalpha.comPhreesia, Inc. 2023 Q2 - Results - Earnings Call PresentationSeptember 5, 2023 | msn.comPhreesia Q2 2024 Earnings PreviewSeptember 5, 2023 | markets.businessinsider.comWhat Wall Street expects from Phreesia's earningsSeptember 5, 2023 | benzinga.comPhreesia's Earnings: A PreviewSeptember 4, 2023 | finance.yahoo.comHow Much Upside is Left in Phreesia (PHR)? Wall Street Analysts Think 27.26%September 4, 2023 | finance.yahoo.comAll You Need to Know About Phreesia (PHR) Rating Upgrade to BuySeptember 2, 2023 | msn.comCanaccord Genuity Reiterates Phreesia (PHR) Buy RecommendationAugust 31, 2023 | finance.yahoo.comShould You Buy and Phreesia (PHR) Ahead of Earnings?August 23, 2023 | fool.comPhreesia (NYSE: PHR)August 16, 2023 | finance.yahoo.comPhreesia Named to The Software Report’s "Top 100 Software Companies" for the Second Consecutive YearSee More Headlines Receive PHR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phreesia and its competitors with MarketBeat's FREE daily newsletter. Email Address PHR Company Calendar Last Earnings9/06/2023Today9/28/2023Next Earnings (Estimated)12/14/2023Fiscal Year End1/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Health Information Services Sub-IndustryN/A SectorMedical Current SymbolNYSE:PHR CUSIPN/A CIK1412408 Webwww.phreesia.com Phone(888) 654-7473Fax646-607-1776Employees1,576Year FoundedN/APrice Target and Rating Average Stock Price Forecast$37.15 High Stock Price Forecast$43.00 Low Stock Price Forecast$29.00 Forecasted Upside/Downside+102.6%Consensus RatingModerate Buy Rating Score (0-4)2.85 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)($2.86) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-176,150,000.00 Net Margins-47.75% Pretax Margin-47.44% Return on Equity-54.52% Return on Assets-41.73% Debt Debt-to-Equity Ratio0.03 Current Ratio2.58 Quick Ratio2.58 Sales & Book Value Annual Sales$280.91 million Price / Sales3.60 Cash FlowN/A Price / Cash FlowN/A Book Value$4.47 per share Price / Book4.10Miscellaneous Outstanding Shares55,210,000Free Float52,007,000Market Cap$1.01 billion OptionableNot Optionable Beta0.63 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Chaim Indig (Age 44)Co-Founder, CEO & Director Comp: $515kMr. Evan Roberts (Age 44)Co-Founder & COO Comp: $400kMr. Michael J. Davidoff (Age 50)Sr. VP of Payer Solutions Comp: $350kMr. David Linetsky (Age 43)Sr. VP of Life Sciences Comp: $551.64kMr. Balaji Gandhi (Age 49)Chief Financial Officer Ms. Janet M. Gunzburg (Age 57)VP, Principal Accounting Officer & Controller Mr. Daniel Nathan (Age 46)Chief Technology Officer Ms. Allison C. Hoffman (Age 52)Gen. Counsel & Sec. Ms. Maureen McKinneyVP of Corp. CommunicationsMs. Kharen HauckVP of MarketingMore ExecutivesKey CompetitorsMultiPlanNYSE:MPLNAmerican WellNYSE:AMWLTabula Rasa HealthCareNASDAQ:TRHCRxSightNASDAQ:RXSTDeciphera PharmaceuticalsNASDAQ:DCPHView All CompetitorsInsiders & InstitutionsJanet GunzburgSold 125 sharesTotal: $2,473.75 ($19.79/share)David LinetskySold 130 sharesTotal: $2,557.10 ($19.67/share)Chaim IndigSold 6,555 sharesTotal: $133,328.70 ($20.34/share)Evan RobertsSold 3,907 sharesTotal: $79,468.38 ($20.34/share)Balaji GandhiSold 3,957 sharesTotal: $80,485.38 ($20.34/share)View All Insider TransactionsView All Institutional Transactions PHR Stock - Frequently Asked Questions Should I buy or sell Phreesia stock right now? 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Phreesia in the last twelve months. There are currently 2 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PHR shares. View PHR analyst ratings or view top-rated stocks. What is Phreesia's stock price forecast for 2023? 13 brokerages have issued 12 month target prices for Phreesia's shares. Their PHR share price forecasts range from $29.00 to $43.00. On average, they predict the company's share price to reach $37.15 in the next year. This suggests a possible upside of 102.6% from the stock's current price. View analysts price targets for PHR or view top-rated stocks among Wall Street analysts. How have PHR shares performed in 2023? Phreesia's stock was trading at $32.36 on January 1st, 2023. Since then, PHR stock has decreased by 43.3% and is now trading at $18.34. View the best growth stocks for 2023 here. Are investors shorting Phreesia? Phreesia saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 1,730,000 shares, a decrease of 15.2% from the August 31st total of 2,040,000 shares. Based on an average daily volume of 410,800 shares, the short-interest ratio is presently 4.2 days. View Phreesia's Short Interest. When is Phreesia's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, December 14th 2023. View our PHR earnings forecast. How were Phreesia's earnings last quarter? Phreesia, Inc. (NYSE:PHR) released its quarterly earnings data on Wednesday, September, 6th. The company reported ($0.68) earnings per share for the quarter, beating the consensus estimate of ($0.71) by $0.03. The firm earned $85.80 million during the quarter, compared to the consensus estimate of $85.26 million. Phreesia had a negative trailing twelve-month return on equity of 54.52% and a negative net margin of 47.75%. The firm's quarterly revenue was up 26.4% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.89) earnings per share. What ETFs hold Phreesia's stock? ETFs with the largest weight of Phreesia (NYSE:PHR) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), Fidelity Disruptive Medicine ETF (FMED) and iShares U.S. Healthcare Providers ETF (IHF) and What guidance has Phreesia issued on next quarter's earnings? Phreesia updated its FY 2025 earnings guidance on Wednesday, September, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $500.00 million-$500.00 million, compared to the consensus revenue estimate of $453.67 million. What is Chaim Indig's approval rating as Phreesia's CEO? 172 employees have rated Phreesia Chief Executive Officer Chaim Indig on Glassdoor.com. Chaim Indig has an approval rating of 73% among the company's employees. What other stocks do shareholders of Phreesia own? Based on aggregate information from My MarketBeat watchlists, some companies that other Phreesia investors own include Fastly (FSLY), Zscaler (ZS), Okta (OKTA), DocuSign (DOCU), HealthEquity (HQY), Block (SQ), Appian (APPN), Walt Disney (DIS), Globant (GLOB) and Invitae (NVTA). When did Phreesia IPO? (PHR) raised $127 million in an initial public offering (IPO) on Thursday, July 18th 2019. The company issued 7,800,000 shares at a price of $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray acted as the underwriters for the IPO. What is Phreesia's stock symbol? Phreesia trades on the New York Stock Exchange (NYSE) under the ticker symbol "PHR." Who are Phreesia's major shareholders? Phreesia's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.25%), Brown Advisory Inc. (6.02%), Jennison Associates LLC (4.79%), Credit Suisse AG (3.50%), Rock Springs Capital Management LP (2.43%) and Franklin Resources Inc. (2.35%). Insiders that own company stock include Allison C Hoffman, Allison C Hoffman, Amy Beth Vanduyn, Balaji Gandhi, Chaim Indig, Cheryl Pegus, David Linetsky, Edward L Cahill, Edward L Cahill, Evan Roberts, Gillian Munson, Janet Gunzburg, Mark Douglas Smith, Michael J Davidoff, Michael Weintraub, Randy Rasmussen and Thomas Altier. View institutional ownership trends. How do I buy shares of Phreesia? Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Phreesia's stock price today? One share of PHR stock can currently be purchased for approximately $18.34. How much money does Phreesia make? Phreesia (NYSE:PHR) has a market capitalization of $1.01 billion and generates $280.91 million in revenue each year. The company earns $-176,150,000.00 in net income (profit) each year or ($2.86) on an earnings per share basis. How many employees does Phreesia have? The company employs 1,576 workers across the globe. How can I contact Phreesia? Phreesia's mailing address is 432 Park Avenue South 12th Floor, New York NY, 10016. The official website for the company is www.phreesia.com. The company can be reached via phone at (888) 654-7473, via email at investors@phreesia.com, or via fax at 646-607-1776. This page (NYSE:PHR) was last updated on 9/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phreesia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.